Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Recovery of Heart Rate Variability in Handball Players (HRV-HANDBAll)

30 août 2026 mis à jour par: Ramiz ARABACI, Uludag University

Effects of Manual Massage and Foam Rolling on Heart Rate Variability Following 20m-Shuttle Run Test in Elite Male Handball Players

This study aimed to compare the acute effects of manual massage (MM) and foam rolling (FR) on heart rate variability (HRV) following a 20 m shuttle run test (20m-SRT) in elite male handball players. It was hypothesized that MM and FR would produce differential acute effects on HRV responses during

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Description détaillée

The aim of present study was to compare the acute effects of manual massage (MM) and foam rolling (FR) on time-domain and frequency-domain HRV parameters following a 20 m shuttle run test (20m-SRT) in elite male handball players. It was hypothesized that MM and FR would produce differential acute effects on HRV responses during. Fifteen elite male handball players voluntarilly participated in present study.

The research utilized a randomized cross-over design. All participants provided written informed consent after being briefed about the aims, procedures, benefits, and risks. Study was conducted in three sessions in onwe week. Fırst session is familiarization, other two sessions are experimental: MM and FR sessions. Participants were instructed to maintain their normal diet, refrain from intense exercise for at least 48 hours before study sessions, avoid alcohol and caffeine intake for 24 hours prior, and consume their last meal at least 3 hours before sessions. In familiarization session, subjects fulfilled Exercise Readiness Questionnaire (EGZ+), measured body composition, after warm-up 20m-SRT, and recovery interventions (MM and FR). Before warm-up - pre-test, during 20-m shuttle run test - test and after recovery - post-test HRV were recorded. In experimental session, after the 20 min standard warm-up including jogging, jumping and stretching volunteers performed 20m-SRT and immediately one of two different recovery interventions. Recovery interventions are MM and FR applied on the lower extremities. All procedures were conducted at the same time of day (14:00-16:00) to minimize circadian rhythm effects. To determine differences in HRV and heart rate across recovery methods and time points, a Two Way Repeated Measures ANOVA was used: 2 Intervention (MM and FR) × 3 Time (Pre-test, Test, Post-test). Bonferroni-adjusted pairwise comparisons performed to identify differences between specific time points and interventions.

Type d'étude

Interventionnel

Inscription (Réel)

15

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

  • Turquie (Türkiye)
      • Bursa, Turquie (Türkiye), 16059
        • Bursa uludag University, Faculty of Sport Sciences

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant
  • Adulte

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

  • Male handball players competing in the Turkish Handball Super League
  • At least 5 years of regular handball training experience
  • Participation in at least 10 official matches during the previous 12 months
  • Minimum 1 year of playing experience in the Turkish Handball Super League
  • No injury resulting in an interruption of training or competition for more than 2 weeks during the previous 6 months
  • No use of stimulants, ergogenic aids, or prohibited performance-enhancing substances

Exclusion Criteria:

  • Current musculoskeletal injury or pain affecting training or match participation
  • History of surgery to the lower or upper extremities within the previous 12 months
  • Presence of cardiovascular, neurological, or metabolic disorders
  • Use of medications that may affect physical performance or neuromuscular function
  • Inability to complete the study procedures or testing protocol
  • Withdrawal of informed consent

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Autre
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation croisée
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Manual Massage (MM)
After the 20 minute standard warm-up including jogging, jumping and stretching participant performed 20 m Shuttle Run Test (20m-SRT), subsequently legs Manual Massage (MM) recovery intervention lasted 20 minutes. Before warm-up, during 20m-SRT and MM HRV was recorded.
Autre: Manul Massage (MM)
MM protocol employed Swedish massage techniques (Hemmings, 2001; Tessier, 2005), including effleurage (light stroking), friction, petrissage (kneading and rolling), vibration and tapotement (light percussion). Massage was applied for 20 minutes total, distributed as: 10 minutes on the right and 10 minutes on the left lower extremity. Posterior lower-extremity massage included the gluteal region, posterior thigh, and calf muscles. Anterior lower-extremity massage included only the quadriceps. Applications were performed from distal to proximal direction using baby oil by certified masseur. Anterior leg massage in a supine position and posterior leg massage in a prone position was applied
Expérimental: Foam Rolling (FR)
After the 20 minute standard warm-up including jogging, jumping and stretching participant performed 20 m Shuttle Run Test (20m-SRT), subsequently legs Foam Rolling (FR) recovery intervention lasted 20 minutes. Before warm-up, during 20m-SRT and FR HRV was recorded.
Autre: Foam Rolling (FR)
A medium density, grid structured foam roller (Blackroll Standard, 33×15×14 cm, PVC polypropylene, Bottighofen, Switzerland) was used. Participants performed self-myofascial release by placing the lower extremities on the foam roller and rolling forward and backward to relax fascia surrounding the muscle with medium pressure. Total duration of FR lasted 20 minutes: 10 minutes left and 10 minutes right lower extremity. Rolling was performed at a controlled cadence (~30 cycles/min) guided by a metronome with moderate pressure.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Heart Rate Variability (HRV)
Délai: From enrollment to the end of treatment at 60 minutes
HRV was recorded by Polar V800 (Polar Electro, Kempele, Finland) heart rate monitor and chest strap of Polar H10 transmitter. HRV time-domain (RR, RMSSD, SDNN) and frequency-domain (VLF, LF, HF) markers and heart rate (HR) were recorded and transferred in Polar Flow. Data set normalized by adopting artefact methodology using Kubios HRV Scientific (Tarvainen et al., 2014). Power values were calculated in normalized units (n.u.). HRV recordings were obtained during three phases: pre exercise (10 min supine rest), during exercise and post exercise recovery phases (10 min supine rest. Participants were instructed to maintain spontaneous but stable breathing during recordings.
From enrollment to the end of treatment at 60 minutes
20 m Shuttle Run Test (VO2max)
Délai: After warm-up 20m-SRT lasted approximately 12-15 minute
20m-SRT was administered following the protocol of Leger and Lambert (1982). The running pace was controlled by "beep test" audio signals. The test started at a speed of 8.5 km·h-¹, increasing by 0.5 km·h-¹ every minute. Participants were required to cover 20 m at each signal. The test ended when a participant failed to complete the 20 m distance three consecutive times. Estimated VO2max values were calculated using the Leger et al. (1988) formula.
After warm-up 20m-SRT lasted approximately 12-15 minute

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Height
Délai: 1 minute during familiarisation session
Standing height was measured with a SECA 216 digital stadiometer with a precision of 0.01 m.
1 minute during familiarisation session
Weight
Délai: 1 minute during familiarisation session
Body weight (kg) were measured using a TANITA BC 418MA Segmental Body Composition Analyzer (±0.50 kg accuracy).
1 minute during familiarisation session
Total Body Fat
Délai: 1 minute during familiarisation session
Total body fat (%) were measured using a TANITA BC 418MA Segmental Body Composition Analyzer (±0.50 kg accuracy).
1 minute during familiarisation session
Body Mass Index
Délai: 1 minute during familiarisation session
Weight and height will be combined to report BMI in kg/m^2
1 minute during familiarisation session

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Uludag University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 mai 2025

Achèvement primaire (Réel)

30 juin 2025

Achèvement de l'étude (Réel)

31 juillet 2025

Dates d'inscription aux études

Première soumission

3 juin 2026

Première soumission répondant aux critères de contrôle qualité

9 juin 2026

Première publication (Réel)

15 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

2 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

30 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Mots clés

Autres numéros d'identification d'étude

  • 2023-20/71014

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

only IPD used in the results publication

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner